Loading page…
Hisamitsu Pharmaceutical Co Inc 2024 Integrated Report
Company: Hisamitsu Pharmaceutical Co Inc
Sector: Manufacturing
Country: Japan
Year: 2024
Type: Integrated Report
Pages: 36
The report describes FY2023 growth to JPY 141.7 billion in net sales, completion and full-scale operation of the SAGA Global Research Center, and progress toward climate goals. The company reports a 29.5% CO2 reduction against FY2013 and targets a 46% reduction in Scopes 1 and 2 by FY2030, followed by carbon neutrality by FY2050.
Indicators available in this report: